Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with stage II-IV CKD not on dialysis, including renal transplant patients, who are receiving erythropoiesis-stimulating agent (ESA) treatment or are ESA-naive
Patients who will not require dialysis within 12 months after the start of Mircera therapy
Patients whose life expectancy is greater than 12 months after Mircera initiation
Patients \>/= 18 years and \</= 75 years of age
Patients who are female and of childbearing potential must be using effective contraception methods
Patients with no contra-indications to ESA treatment (for example, hypersensitivity, non-controlled hypertension and others according to the local SmPC)
Patients who have given written informed consent where local regulations allow or require it
